Two L-nucleosides, L-30-amino-30-deoxy-N6-dimethyladenosine (L-30-ADMdA) 1, previously synthesized in our laboratory, and the novel L-30-amino-30-deoxy-N6-methyladenosine-50-N-methyluronamide (L-30-AM-MECA) 2 were evaluated in an ischemia/reperfusion model on Langendorff perfused mouseheart. L-30-ADMdA 1 was found to enhance functional recovery from ischemia (32.2 ± 3.7 cm H2O/s % ratepressure product, compared to 21.3 ± 1.4 for the control and 30.7 ± 3.4 for adenosine) and increase the time to onset of ischemic contracture (14.5 ± 0.9 min, compared to 10.5 ± 1.0 min for the control and 13.6 ± 0.6 min for adenosine) comparable to adenosine. Consistent with the functional recovery data,decreased infarction area was seen in the case of 1 (19.1 ± 8.4, compared to 40.5 ± 7.2% for the control and 11.5 ± 2.1% for adenosine). In contrast, L-30-AM-MECA 2 did not show significant functional recovery,increased onset of contracture, nor decreased infarction area compared to control. Unlike adenosine,neither 1 nor 2 induced cardiac standstill in mouse heart.

Novel L-adenosine analogs as cardioprotective agents

CHIACCHIO M;
2009-01-01

Abstract

Two L-nucleosides, L-30-amino-30-deoxy-N6-dimethyladenosine (L-30-ADMdA) 1, previously synthesized in our laboratory, and the novel L-30-amino-30-deoxy-N6-methyladenosine-50-N-methyluronamide (L-30-AM-MECA) 2 were evaluated in an ischemia/reperfusion model on Langendorff perfused mouseheart. L-30-ADMdA 1 was found to enhance functional recovery from ischemia (32.2 ± 3.7 cm H2O/s % ratepressure product, compared to 21.3 ± 1.4 for the control and 30.7 ± 3.4 for adenosine) and increase the time to onset of ischemic contracture (14.5 ± 0.9 min, compared to 10.5 ± 1.0 min for the control and 13.6 ± 0.6 min for adenosine) comparable to adenosine. Consistent with the functional recovery data,decreased infarction area was seen in the case of 1 (19.1 ± 8.4, compared to 40.5 ± 7.2% for the control and 11.5 ± 2.1% for adenosine). In contrast, L-30-AM-MECA 2 did not show significant functional recovery,increased onset of contracture, nor decreased infarction area compared to control. Unlike adenosine,neither 1 nor 2 induced cardiac standstill in mouse heart.
2009
L-Nucleoside; Adenosine; Cardioprotection
File in questo prodotto:
File Dimensione Formato  
BiorMedChem2009.pdf

solo gestori archivio

Licenza: Non specificato
Dimensione 241.16 kB
Formato Adobe PDF
241.16 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/6980
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 15
social impact